Vemurafenib for BRAFV600E-positive metastatic papillary thyroid cancer – Authors' response

Marcia S. Brose, Nathan Singh

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e469
JournalThe Lancet Oncology
Volume17
Issue number11
DOIs
StatePublished - Nov 1 2016
Externally publishedYes

Cite this